“…The eye is the only part of the CNS that can be visualized noninvasively (Hill et al, 2014; MacGillivray et al, 2014) and it shares many features with the rest of the brain (MacCormick et al, 2015), making it an ideal candidate for the development of biomarkers to diagnose CNS disorders. Visual assessments, such as optical coherence tomography and electroretinography, have been widely used, for over a decade, to detect several diseases, such as cerebral malaria (MacCormick et al, 2015), stroke (Baker et al, 2008), diabetes mellitus (Cheung et al, 2010), hypertension (Wong and Mitchell, 2007), cardiovascular disease (Liew et al, 2011), schizophrenia (Chu et al, 2012; Silverstein et al, 2015) and Parkinson鈥檚 disease (Tian et al, 2011; Lee et al, 2014).…”